These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 35070000

  • 1. Liver manifestations and complications in inflammatory bowel disease: A review.
    Gaspar R, Branco CC, Macedo G.
    World J Hepatol; 2021 Dec 27; 13(12):1956-1967. PubMed ID: 35070000
    [Abstract] [Full Text] [Related]

  • 2. Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.
    Rojas-Feria M, Castro M, Suárez E, Ampuero J, Romero-Gómez M.
    World J Gastroenterol; 2013 Nov 14; 19(42):7327-40. PubMed ID: 24259964
    [Abstract] [Full Text] [Related]

  • 3. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders.
    Mazza S, Soro S, Verga MC, Elvo B, Ferretti F, Cereatti F, Drago A, Grassia R.
    World J Hepatol; 2021 Dec 27; 13(12):1828-1849. PubMed ID: 35069993
    [Abstract] [Full Text] [Related]

  • 4. Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review.
    Fousekis FS, Theopistos VI, Katsanos KH, Tsianos EV, Christodoulou DK.
    Gastroenterology Res; 2018 Apr 27; 11(2):83-94. PubMed ID: 29707074
    [Abstract] [Full Text] [Related]

  • 5. Hepatic manifestations of inflammatory bowel diseases.
    Restellini S, Chazouillères O, Frossard JL.
    Liver Int; 2017 Apr 27; 37(4):475-489. PubMed ID: 27712010
    [Abstract] [Full Text] [Related]

  • 6. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease.
    Navaneethan U, Shen B.
    Inflamm Bowel Dis; 2010 Sep 27; 16(9):1598-619. PubMed ID: 20198712
    [Abstract] [Full Text] [Related]

  • 7. Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study.
    Fousekis FS, Katsanos KH, Theopistos VI, Baltayiannis G, Kosmidou M, Glantzounis G, Christou L, Tsianos EV, Christodoulou DK.
    BMC Gastroenterol; 2019 Apr 03; 19(1):48. PubMed ID: 30943899
    [Abstract] [Full Text] [Related]

  • 8. The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.
    Bernstein CN, Benchimol EI, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Kaplan GG.
    J Can Assoc Gastroenterol; 2019 Feb 03; 2(Suppl 1):S73-S80. PubMed ID: 31294387
    [Abstract] [Full Text] [Related]

  • 9. Frequency of Hepatobiliary Manifestations and Concomitant Liver Disease in Inflammatory Bowel Disease Patients.
    Silva J, Brito BS, Silva INN, Nóbrega VG, da Silva MCSM, Gomes HDN, Fortes FM, Pimentel AM, Mota J, Almeida N, Surlo VC, Lyra A, Rocha R, Santana GO.
    Biomed Res Int; 2019 Feb 03; 2019():7604939. PubMed ID: 30834274
    [Abstract] [Full Text] [Related]

  • 10. Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks.
    Massironi S, Pirola L, Mulinacci G, Ciaccio A, Viganò C, Palermo A, Zilli A, Invernizzi P, Danese S.
    Inflamm Bowel Dis; 2023 Sep 01; 29(9):1477-1487. PubMed ID: 36040402
    [Abstract] [Full Text] [Related]

  • 11. Current approach to hepatobiliary manifestations in inflammatory bowel disease.
    Majchrzak K, Dudek P, Talar-Wojnarowska R, Fichna J.
    J Physiol Pharmacol; 2021 Oct 01; 72(5):. PubMed ID: 35158328
    [Abstract] [Full Text] [Related]

  • 12. [Hepatobiliary Manifestation of Inflammatory Bowel Disease].
    Seo KI, Kang SB.
    Korean J Gastroenterol; 2019 May 25; 73(5):248-259. PubMed ID: 31132831
    [Abstract] [Full Text] [Related]

  • 13. Hepatobiliary manifestations in children with inflammatory bowel disease: A single-center experience in a low/middle income country.
    El-Shabrawi MH, Tarek S, Abou-Zekri M, Meshaal S, Enayet A, Mogahed EA.
    World J Gastrointest Pharmacol Ther; 2020 Aug 08; 11(3):48-58. PubMed ID: 32844043
    [Abstract] [Full Text] [Related]

  • 14. Liver Pathology in Children with Diagnosed Inflammatory Bowel Disease-A Single Center Experience.
    Daniluk U, Kwiatek-Sredzinska K, Jakimiec P, Daniluk J, Czajkowska A, Lebensztejn DM.
    J Clin Med; 2021 Nov 17; 10(22):. PubMed ID: 34830641
    [Abstract] [Full Text] [Related]

  • 15. Appearance of hepatobiliary diseases in a population-based cohort with inflammatory bowel diseases (Inflammatory Bowel Disease Cohort of the Uppsala Region).
    Rönnblom A, Holmström T, Tanghöj H, Rorsman F, Sjöberg D.
    J Gastroenterol Hepatol; 2015 Aug 17; 30(8):1288-92. PubMed ID: 25777994
    [Abstract] [Full Text] [Related]

  • 16. Hepatic Complications of Inflammatory Bowel Disease.
    Mahfouz M, Martin P, Carrion AF.
    Clin Liver Dis; 2019 May 17; 23(2):191-208. PubMed ID: 30947871
    [Abstract] [Full Text] [Related]

  • 17. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
    Kujundzić M.
    Acta Med Croatica; 2013 Apr 17; 67(2):195-201. PubMed ID: 24471303
    [Abstract] [Full Text] [Related]

  • 18. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
    Bjarnason I, Hayee B, Pavlidis P, Kvasnovsky C, Scalori A, Sisson G, Charlesworth A, Shaikh H, Bjornsson E, Heneghan MA.
    EBioMedicine; 2015 Oct 17; 2(10):1523-7. PubMed ID: 26629548
    [Abstract] [Full Text] [Related]

  • 19. [Hepatobiliary complications of idiopathic intestinal inflammations].
    Lukás M.
    Cas Lek Cesk; 1997 Feb 12; 136(4):106-10. PubMed ID: 9221179
    [Abstract] [Full Text] [Related]

  • 20. Hepatobiliary manifestations of inflammatory bowel disease.
    Yarur AJ, Czul F, Levy C.
    Inflamm Bowel Dis; 2014 Sep 12; 20(9):1655-67. PubMed ID: 24874461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.